CytoSolv
Tiverton
About CytoSolv
CytoSolv Inc. engages in the development of a technology for the cure of diabetic ulcers. The company was founded in 2009 and is based in Tiverton, Rhode Island.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $650.0K
- Funding stage: M&A
- Last round: Grant (Dec 2012)
- Website: cytosolv.com
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/cytosolv-1556985 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.